A Prospective, Multicentre, Controlled, Observational Study to Evaluate the Performance of Patient Support Programme (PSP) in Improving Patient Adherence With Adjuvant Aromatase Inhibitors (AI) Medication for Postmenopausal, Early Stage Breast Cancer.
Phase of Trial: Phase IV
Latest Information Update: 28 Nov 2011
At a glance
- Drugs Anastrozole; Letrozole
- Indications Early breast cancer
- Focus Therapeutic Use
- Acronyms ARI-NIS
- Sponsors AstraZeneca
- 07 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Dec 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 23 Dec 2009 Planned end date changed from 1 Feb 2011 to 1 Sep 2010 as reported by ClinicalTrials.gov.